| 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia D Khanna, JD Fitzgerald, PP Khanna, S Bae, MK Singh, T Neogi, ... Arthritis care & research 64 (10), 1431-1446, 2012 | 2561* | 2012 |
| 2020 American College of Rheumatology guideline for the management of gout JD FitzGerald, N Dalbeth, T Mikuls, R Brignardello‐Petersen, G Guyatt, ... Arthritis & Rheumatology 72 (6), 879-895, 2020 | 1054 | 2020 |
| Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases JY Park, MH Pillinger, SB Abramson Clinical immunology 119 (3), 229-240, 2006 | 892 | 2006 |
| Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007–2016 M Chen‐Xu, C Yokose, SK Rai, MH Pillinger, HK Choi Arthritis & rheumatology 71 (6), 991-999, 2019 | 784 | 2019 |
| Periodontal disease and the oral microbiota in new‐onset rheumatoid arthritis JU Scher, C Ubeda, M Equinda, R Khanin, Y Buischi, A Viale, L Lipuma, ... Arthritis & Rheumatism 64 (10), 3083-3094, 2012 | 567 | 2012 |
| Narrative review: the pathophysiology of fibromyalgia AM Abeles, MH Pillinger, BM Solitar, M Abeles Annals of internal medicine 146 (10), 726-734, 2007 | 519 | 2007 |
| The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction A Mor, SB Abramson, MH Pillinger Clinical immunology 115 (2), 118-128, 2005 | 489 | 2005 |
| 15d-PGJ2: the anti-inflammatory prostaglandin? JU Scher, MH Pillinger Clinical immunology 114 (2), 100-109, 2005 | 428 | 2005 |
| C-reactive protein and clinical outcomes in patients with COVID-19 NR Smilowitz, D Kunichoff, M Garshick, B Shah, M Pillinger, JS Hochman, ... European heart journal 42 (23), 2270-2279, 2021 | 419 | 2021 |
| The neutrophil: function and regulation in innate and humoral immunity ND Burg, MH Pillinger Clinical immunology 99 (1), 7-17, 2001 | 414 | 2001 |
| Colchicine: old and new A Slobodnick, B Shah, MH Pillinger, S Krasnokutsky The American journal of medicine 128 (5), 461-470, 2015 | 328 | 2015 |
| The anti-inflammatory effects of prostaglandins JU Scher, MH Pillinger Journal of Investigative Medicine 57 (6), 703-708, 2009 | 307 | 2009 |
| Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial JC Tardif, N Bouabdallaoui, PL L'allier, D Gaudet, B Shah, MH Pillinger, ... The Lancet Respiratory Medicine 9 (8), 924-932, 2021 | 304 | 2021 |
| Adenosine A2A receptors play a role in the pathogenesis of hepatic cirrhosis ESL Chan, MC Montesinos, P Fernandez, A Desai, DL Delano, H Yee, ... British journal of pharmacology 148 (8), 1144, 2006 | 283 | 2006 |
| Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor M Attur, HE Al-Mussawir, J Patel, A Kitay, M Dave, G Palmer, MH Pillinger, ... The Journal of Immunology 181 (7), 5082-5088, 2008 | 278 | 2008 |
| Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout DB Crittenden, RA Lehmann, L Schneck, RT Keenan, B Shah, ... The Journal of rheumatology 39 (7), 1458-1464, 2012 | 270 | 2012 |
| Update on colchicine, 2017 A Slobodnick, B Shah, S Krasnokutsky, MH Pillinger Rheumatology 57 (suppl_1), i4-i11, 2018 | 269 | 2018 |
| Carboxyl methylation of Ras-related proteins during signal transduction in neutrophils MR Philips, MH Pillinger, R Staud, C Volker, MG Rosenfeld, ... Science 259 (5097), 977-980, 1993 | 263 | 1993 |
| The neutrophil in rheumatoid arthritis MH Pillinger, SB Abramson Rheumatic Disease Clinics of North America 21 (3), 691-714, 1995 | 235 | 1995 |
| Interleukin-6 in the pathogenesis of rheumatoid arthritis. JY Park, MH Pillinger Bulletin of the NYU hospital for joint diseases 65, S4-10, 2007 | 231 | 2007 |
